Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients
Open Access
- 7 October 2020
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 12 (564)
- https://doi.org/10.1126/scitranslmed.abd5487
Abstract
Children and youth infected with SARS-CoV-2 have milder disease than do adults and, even among those with the recently described multi-system inflammatory syndrome (MIS-C), mortality is rare. The reasons for the differences in clinical manifestations are unknown, but suggest that age-dependent factors may modulate the anti-viral immune response. We compared cytokine, humoral, and cellular immune responses in pediatric (children and youth, age < 24 years) (n=65) and adult (n=60) patients with COVID-19 at a metropolitan hospital system in New York City. The pediatric patients had a shorter length of stay, decreased requirement for mechanical ventilation and lower mortality compared to adults. The serum concentrations of IL-17A and IFN-γ, but not TNF-α or IL-6, were inversely related to age. Adults mounted a more robust T cell response to the viral spike protein compared to pediatric patients as evidenced by increased expression of CD25+ on CD4+ T cells and the frequency of IFN-γ+CD4+ T cells. Moreover, serum neutralizing antibody titers and antibody-dependent cellular phagocytosis were higher in adults compared to pediatric COVID-19 patients. The neutralizing antibody titer correlated positively with age and negatively with IL-17A and IFN-γ serum concentrations. There were no differences in anti-spike protein antibody titers to other human coronaviruses. Together these findings demonstrate that the poor outcome in hospitalized adults with COVID-19 compared to children may not be attributable to a failure to generate adaptive immune responses.Funding Information
- National Institutes of Health (UL1 TR001073)
- National Institute of Allergy and Infectious Diseases (R01AI134367)
- National Institute of Allergy and Infectious Diseases (R01AI134367)
- National Institute of Allergy and Infectious Diseases (T32AI007501)
- National Institute of Allergy and Infectious Diseases (P30AI124414)
- National Institute of Allergy and Infectious Diseases (U19 AI142777)
This publication has 25 references indexed in Scilit:
- Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infectionJCI Insight, 2019
- The age of adolescenceThe Lancet Child & Adolescent Health, 2018
- Aging impairs both primary and secondary RIG-I signaling for interferon induction in human monocytesScience Signaling, 2017
- Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling studyThe Lancet, 2017
- Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virusNature Immunology, 2016
- Protective role of Th17 cells in pulmonary infectionVaccine, 2016
- CD161 Expression Defines a Th1/Th17 Polyfunctional Subset of Resident Memory T Lymphocytes in Bronchoalveolar CellsPLOS ONE, 2015
- Age-dependent dysregulation of innate immunityNature Reviews Immunology, 2013
- Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexesNature Medicine, 2010
- Pulmonary epithelial cells are a source of interferon‐γ in response to Mycobacterium tuberculosis infectionImmunology & Cell Biology, 2007